Beijing Scitop Financials
| 300858 Stock | 16.47 0.25 1.54% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 99.4 M | 73.5 M |
|
|
Beijing | Select Account or Indicator |
Understanding current and past Beijing Scitop Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Beijing Scitop's financial statements are interrelated, with each one affecting the others. For example, an increase in Beijing Scitop's assets may result in an increase in income on the income statement.
Please note, the presentation of Beijing Scitop's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Beijing Scitop's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Beijing Scitop's management manipulating its earnings.
Beijing Scitop Stock Summary
Beijing Scitop competes with Southchip Semiconductor, Anhui Huilong, Shaanxi Construction, Will Semiconductor, and Shenwu Energy. Beijing Scitop is entity of China. It is traded as Stock on SHE exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE100004181 |
| Business Address | 31 Mangniuhe Road, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.scitop.cn |
| Phone | 86 40 0650 6833 |
You should never invest in Beijing Scitop without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Beijing Stock, because this is throwing your money away. Analyzing the key information contained in Beijing Scitop's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Beijing Scitop Key Financial Ratios
Beijing Scitop's financial ratios allow both analysts and investors to convert raw data from Beijing Scitop's financial statements into concise, actionable information that can be used to evaluate the performance of Beijing Scitop over time and compare it to other companies across industries.| Revenue | 299.24 M | ||||
| Gross Profit | 191.88 M | ||||
| EBITDA | 76.02 M | ||||
| Net Income | 93.48 M | ||||
| Total Asset | 1.81 B |
Beijing Scitop Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 466.0M | 999.2M | 1.0B | 1.8B | 1.8B | 974.0M | |
| Other Current Liab | 7.7M | 5.8M | 21.5M | 36.9M | 1.4M | 1.4M | |
| Other Liab | 2.4M | 2.2M | 3.5M | 2.2M | 2.0M | 2.4M | |
| Net Tangible Assets | 377.3M | 911.9M | 911.3M | 1.6B | 1.9B | 2.0B | |
| Retained Earnings | 164.4M | 261.0M | 288.0M | 323.4M | 323.8M | 206.1M | |
| Accounts Payable | 42.5M | 46.3M | 27.3M | 36.4M | 16.1M | 27.0M | |
| Cash | 100.2M | 202.3M | 481.8M | 875.4M | 191.6M | 283.1M | |
| Other Assets | 6.2M | 1.7M | 6.3M | 162.2M | 186.6M | 195.9M | |
| Net Receivables | 107.5M | 119.9M | 115.1M | 103.3M | 65.4M | 79.4M | |
| Inventory | 30.2M | 44.7M | 52.8M | 50.9M | 39.2M | 43.3M | |
| Other Current Assets | 10.5M | 6.2M | 7.0M | 10.5M | 498.2M | 523.1M | |
| Total Liab | 66.1M | 66.7M | 73.3M | 94.0M | 77.1M | 79.4M | |
| Total Current Assets | 249.0M | 767.2M | 752.6M | 1.3B | 955.6M | 648.2M | |
| Intangible Assets | 20.6M | 18.8M | 54.2M | 53.0M | 51.1M | 35.7M | |
| Net Invested Capital | 399.8M | 932.6M | 967.4M | 1.7B | 1.7B | 993.2M | |
| Net Working Capital | 185.3M | 702.8M | 690.1M | 1.2B | 896.9M | 635.3M |
Beijing Scitop Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | 17.3M | 16.6M | 14.6M | 15.8M | 8.6M | 11.7M | |
| Net Interest Income | (224.4K) | 3.5M | 6.3M | 3.2M | 23.5M | 24.6M | |
| Interest Expense | 337.5K | 66.3K | 439.1K | 405.3K | 500.9K | 266.8K | |
| Total Revenue | 308.1M | 339.2M | 364.6M | 369.2M | 299.2M | 349.6M | |
| Gross Profit | 157.5M | 163.9M | 183.5M | 191.9M | 163.3M | 174.1M | |
| Operating Income | 108.7M | 110.4M | 94.4M | 115.8M | 73.5M | 99.4M | |
| Ebit | 101.0M | 103.4M | 89.6M | 115.8M | 133.2M | 97.5M | |
| Research Development | 14.8M | 17.6M | 27.2M | 22.1M | 34.2M | 21.1M | |
| Cost Of Revenue | 150.6M | 175.3M | 181.2M | 177.3M | 135.9M | 175.5M | |
| Income Before Tax | 110.6M | 113.2M | 124.2M | 125.7M | 102.0M | 109.3M | |
| Net Income | 93.3M | 96.6M | 109.5M | 109.9M | 93.5M | 93.2M | |
| Income Tax Expense | 17.3M | 16.6M | 14.6M | 15.8M | 18.1M | 17.1M | |
| Interest Income | 156.9K | 3.5M | 6.7M | 3.6M | 24.0M | 25.2M | |
| Ebitda | 116.1M | 123.0M | 140.7M | 144.1M | 165.7M | 133.3M |
Beijing Scitop Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Beijing Scitop Bio. It measures of how well Beijing is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Beijing Scitop brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Beijing had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Beijing Scitop has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (1.7M) | (14.6M) | (8.1M) | 1.9M | 11.7M | 12.3M | |
| Investments | 1.3M | (383.0M) | 302.7M | (288.9M) | (739.7M) | (702.7M) | |
| Change In Cash | 45.4M | 102.1M | 279.5M | 393.5M | (686.8M) | (652.4M) | |
| Net Borrowings | 8.3M | (8M) | (788.0K) | (1.2M) | (1.4M) | (1.5M) | |
| Depreciation | 5.2M | 9.8M | 15.9M | 18.0M | 20.3M | 10.9M | |
| Dividends Paid | 69.6M | 356.2K | 82.5M | 74.5M | 52.7M | 57.1M | |
| Capital Expenditures | 46.2M | 21.3M | 67.6M | 84.2M | 178.5M | 187.4M | |
| Net Income | 93.3M | 96.6M | 109.5M | 109.9M | 93.5M | 93.2M | |
| End Period Cash Flow | 100.1M | 202.2M | 481.8M | 875.3M | 188.5M | 282.6M | |
| Change To Netincome | (1.9M) | (4.9M) | (28.5M) | (10.2M) | (9.2M) | (8.7M) | |
| Free Cash Flow | 52.0M | 45.4M | 42.7M | 64.3M | (71.2M) | (67.6M) | |
| Other Non Cash Items | 986.9K | (1.3M) | (4.3M) | (1.4M) | (19.4M) | (18.5M) |
Beijing Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Beijing Scitop's current stock value. Our valuation model uses many indicators to compare Beijing Scitop value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Beijing Scitop competition to find correlations between indicators driving Beijing Scitop's intrinsic value. More Info.Beijing Scitop Bio is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.37 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Beijing Scitop Bio is roughly 2.73 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Beijing Scitop by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Beijing Scitop's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Beijing Scitop Bio Systematic Risk
Beijing Scitop's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Beijing Scitop volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Beijing Scitop Bio correlated with the market. If Beta is less than 0 Beijing Scitop generally moves in the opposite direction as compared to the market. If Beijing Scitop Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Beijing Scitop Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Beijing Scitop is generally in the same direction as the market. If Beta > 1 Beijing Scitop moves generally in the same direction as, but more than the movement of the benchmark.
Beijing Scitop Bio Total Assets Over Time
Beijing Scitop December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Beijing Scitop help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Beijing Scitop Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Beijing Scitop Bio based on widely used predictive technical indicators. In general, we focus on analyzing Beijing Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Beijing Scitop's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.25 | |||
| Information Ratio | 0.0456 | |||
| Maximum Drawdown | 24.16 | |||
| Value At Risk | (4.20) | |||
| Potential Upside | 5.82 |
Complementary Tools for Beijing Stock analysis
When running Beijing Scitop's price analysis, check to measure Beijing Scitop's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beijing Scitop is operating at the current time. Most of Beijing Scitop's value examination focuses on studying past and present price action to predict the probability of Beijing Scitop's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beijing Scitop's price. Additionally, you may evaluate how the addition of Beijing Scitop to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |